Table 3 Current medication among the groups
Medications | NGR (Group I) (n = 1170) | IGR (Group II) (n = 389) | DM (Group III) (n = 343) |
|---|---|---|---|
Antihypertensive drugs | Â | Â | Â |
Diuretic (%) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
ARB (%) | 77 (6.6) | 25 (6.4) | 46 (13.4) |
ACEI (%) | 27 (2.3) | 16 (4.1) | 23 (6.7) |
β-blocker (%) | 12 (1.0) | 10 (2.6) | 5 (1.5) |
CCB (%) | 86 (7.4) | 53 (13.6) | 59 (17.2) |
Others (%) | 36 (3.1) | 24 (6.2) | 10 (2.9) |
Antidiabetic drugs |  |  | Self-reported T2DM (n = 178) |
Insulin (%) | Â | Â | 31 (17.4) |
Oral hypoglycemic drugs | Â | Â | Â |
Metformin (%) | Â | Â | 61 (34.3) |
Sulphonylurea (%) | Â | Â | 41 (23.0) |
Glinide (%) | Â | Â | 26 (14.6) |
Thiazolidinedione (%) | Â | Â | 10 (5.6) |
α-Glucosidase inhibitor (%) |  |  | 24 (13.5) |
Others (%) | Â | Â | 3 (1.7) |